NLRP3 and Thrombocytopenia: We found that NAC pretreatment could inhibit the expression of platelet NLRP3 and cleaved caspase-1 as well as platelet activation and thrombocytopenia in HS rats, indicating that ROS could activate NLRP3 inflammasome in platelets and may be invovled in thrombocytopenia.